Institutional investors hold a majority ownership of BMY through the 72.93% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended December 2016, these large investors purchased a net $9.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BMO ASSET MANAGEMENT CORP. Bought 4.4 Million shares of Bristol-Myers Squibb
VANGUARD INVESTMENTS AUSTRALIA L... Bought 450.3 Thousand shares of Bristol-Myers Squibb
ETHENEA INDEPENDENT INVESTORS SA Bought 400.0 Thousand shares of Bristol-Myers Squibb